CSIMarket
 

Oak Street Health Inc   (NYSE: OSH)
Other Ticker:  
 

Oak Street Health Inc 's Working Capital Per Sales

OSH's Working Capital and Revenue growth



OSH Working Capital Per Revenue (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Working Capital Change -32.06 % -43.81 % -47.46 % -51.73 % -44.38 %
Y / Y Revenue Change 46.36 % 46.59 % 40.39 % 48.31 % 73.17 %
Working Capital Per Revenue 0.19 0.23 0.3 0.38 0.51
Total Ranking # 1348 # 1652 # 818 # 1648 # 1610
Seq. Working Capital Change 5.76 % -22.39 % 0.33 % -17.51 % -12.53 %
Seq. Revenue Change 30.17 % 5.86 % 4.2 % 1.93 % 30.37 %





Comment on OSH's Working Capital Per Revenue in the first quarter 2023
Oak Street Health Inc 's Working Capital Per Revenue in the Q1 2023 sequentially fell to 0.19 below the company average.

Within Healthcare sector 60 other companies have achieved lower Working Capital Per Revenue during the Q1 2023. While Oak Street Health Inc Working Capital Per Revenue overall ranking has impoved so far in the Q1 2023 to 1348, from total ranking in the fourth quarter 2022 at 1652.
Working Capital Per Revenue Ranking
Within: No.
Industry # 11
Sector # 61
S&P 500 # 1348


Working Capital Per Revenue Statistics
High Average Low
0.67
0.41
0.17
(Dec 31 2021)   (Sep 30 2020)



Financial Statements
Oak Street Health Inc 's Working Capital $ 418 Millions Visit OSH's Balance sheet
Oak Street Health Inc 's Revenues $ 752 Millions Visit OSH's Income Statement
Where are OSH's Sales coming from? Visit OSH's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2023, within Healthcare Sector Working Capital Per Revenue
Moderna Inc   0.52 
Prophase Labs Inc   0.52 
Myomo Inc   0.51 
Amgen Inc   0.51 
Orasure Technologies Inc  0.50 
Novabay Pharmaceuticals Inc   0.50 
Sab Biotherapeutics Inc   0.50 
Zoetis Inc   0.49 
Dr Reddy s Laboratories Limited  0.49 
Cumberland Pharmaceuticals Inc  0.49 
Sharecare Inc   0.49 
Surgalign Holdings Inc   0.48 
Luna Innovations Inc  0.48 
Orgenesis Inc  0.48 
Xtant Medical Holdings Inc   0.47 
Rigel Pharmaceuticals Inc  0.46 
Irhythm Technologies Inc   0.46 
West Pharmaceutical Services Inc   0.46 
Atricure Inc   0.46 
Bruker Corporation  0.45 
Jazz Pharmaceuticals Plc  0.45 
Docgo Inc   0.44 
Iridex Corp  0.43 
Smiledirectclub Inc   0.43 
Emergent Biosolutions Inc   0.42 
Pro dex Inc   0.42 
Haemonetics Corporation  0.42 
Edwards Lifesciences Corporation  0.42 
Nabriva Therapeutics Plc  0.41 
Phibro Animal Health Corporation  0.41 
Date modified: 2023-05-11T12:26:52+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com